BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Fujisawa Pharmaceutical Co., Ltd. 

4-7, Doshomachi 3-chome

Chuo-ku  Osaka  541-8514  Japan
Phone: 81-06-6202-1141 Fax: 81-06-6206-7926


SEARCH JOBS




Industry
Pharmaceutical






 Company News
Yamanouchi Pharmaceutical Co., Ltd. And Fujisawa Pharmaceutical Co., Ltd. Unite To Form Astellas Pharma Inc., North American Headquarters To Be In Chicago10/19/2005 5:13:11 PM
Fujisawa Pharmaceutical Co., Ltd. To Outsource Cefzon Bulk Production To API Corporation10/19/2005 5:13:07 PM
Fujisawa Healthcare, Inc. Release: Mycamine(TM) Receives FDA Approval10/19/2005 5:13:03 PM
Gloucester Pharmaceuticals, Inc. Initiates Pivotal Trial With FK228 In Cutaneous T-Cell Lymphoma; FDA Approves Trial Protocol Under Special Protocol Assessment10/19/2005 5:12:52 PM
Merger Mania Besets Japanese Pharmaceuticals10/19/2005 5:12:49 PM
Fujisawa Pharmaceutical Co., Ltd. And Carlsson Research AB Conclude Licensing Agreement For Antipsychotic Agent ACR-1610/19/2005 5:12:39 PM
Cardiome Pharma Corp. (COM.TO) Completes ACT 3 Enrollment10/19/2005 5:12:08 PM
Yamanouchi Pharmaceutical Co., Ltd., Fujisawa Pharmaceutical Co., Ltd. To Become Astellas Post-Merger; $7.12 Billion10/19/2005 5:11:29 PM
Fujisawa Pharmaceutical Co., Ltd. And Yamanouchi Pharmaceutical Co., Ltd. Will Establish Zepharma Inc., An OTC Pharmaceutical Company10/19/2005 5:11:27 PM
Tercica, Inc. Licenses Patent Rights To rhIGF-1 From Fujisawa Pharmaceutical Co., Ltd. In Extreme Insulin Resistance10/19/2005 5:11:05 PM
123